Quantcast
Connect with us

Mylan pushed for law to make EpiPens mandatory in US schools — then fled overseas to avoid taxes

Published

on

EpiPens are mandatory for public schools in at least 11 states after Congress passed a law recommending their use — but the drug’s manufacturer pays no U.S. taxes at all after relocating overseas.

Mylan spent $4 million lobbying Congress to pass the 2013 School Access to Emergency Epinephrine Act, which offers incentives to schools to stock the potentially life-saving auto-injectors.

ADVERTISEMENT

About a year and a half later, Mylan completed a corporate inversion to change its legal residence to the Netherlands, a tax haven, while keeping its headquarters and most of its employees in the Pittsburgh area.

The move allowed Mylan to cut its U.S. effective tax rate from 9.4 percent in 2013, the year Congress helped protect its market dominance, to negative 4.7 percent in 2015, according the group Americans For Tax Fairness.

Mylan’s worldwide effective tax rate fell after moving to the Netherlands from 16.2 percent to 7.4 percent — even as its global profits shot up by 22.5 percent between 2013 and 2015.

The company receives millions in U.S. taxpayer funding through federal programs such as Medicaid and the Children’s Health Insurance Program, which has helped offset consumer costs as Mylan has jacked up EpiPen prices.

EpiPens now cost $609, more than twice the $265 rate in 2013 and more than five times higher than their $104 cost in 2009, not long after the company acquired the drug from the German drugmaker Merck.

ADVERTISEMENT

The company’s CEO, Heather Bresch, has raised her own pay at similar rates to the drug she lobbied Congress to promote through federal law.

Bresch took home $4.9 million in 2009, but last year she made $13.1 million — and the year before, when she moved Mylan overseas after securing the Emergency Epinephrine Act, she made a whopping $25.8 million.

The CEO’s father, U.S. Sen. Joe Manchin (D-WV), was not among the 27 Democratic sponsors of the bill — which also drew 10 Republican co-sponsors and one independent.

ADVERTISEMENT

The pharmaceutical company’s “EpiPen4Schools” program, which started in August 2012, before the bill was passed but after it was introduced, offers free or discounted EpiPens to schools with one catch.

To qualify for the discounted $112.10 price, schools must agree not to purchase similar products — such as the lesser known Adrenaclick — from Mylan’s competitors.

ADVERTISEMENT

A spokesperson for the company said the competition requirement was no longer part of the program and did not say when it was ended, but it was apparently still shown on order forms as recently as June 2015, STAT reported.

Mylan also helps keep the drug’s price artificially high by funding Snack Safely, the public relations arm of the nonprofit Food Allergy Research and Education group.

Snack Safely publishes social media-ready blog posts promoting Mylan’s interests — such as arguing against a petition drive to make EpiPens available over-the-counter, which would dramatically cut its cost.

ADVERTISEMENT

Watch Bresch discuss Mylan’s corporate inversion in this 2015 interview with Fortune:

READ MORE:

 


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump blows up at Fox News reporter for asking him about disbanding pandemic team

Published

on

On Wednesday, President Donald Trump lost his temper at a coronavirus press briefing when Fox News correspondent John Roberts asked him about his administration disbanding the pandemic response team.

"We didn't do that. That turned out to be a false story," said Trump. (It is not a false story.) "Now you're starting to go — are you working for CNN?"

"I'm pointing out what they have said and what you have said, that's all," said Roberts.

"Fox isn't so easy either, don't kid yourself," whined Trump. "Look, John, let me tell you something. You know that's a false story. What you just said is a false story, this doctor knows it better than anybody ... you shouldn't be repeating a story that you know is false."

Continue Reading

Breaking Banner

More than 1 in 5 ventilators in federal government stockpile is holding for emergencies don’t work

Published

on

As the coronavirus is raging through the United States, President Donald Trump has begun releasing personal protective equipment from federal stockpiles as well as much-needed ventilators. Unfortunately, however, one in five ventilators from the government don't work.

The New York Times reported Wednesday that there are 10,000 ventilators that the government is holding back for the next wave of the emergency.

"But what federal officials have neglected to mention is that more than 2,000 of the lifesaving devices are unavailable after the contract to maintain the government’s stockpile lapsed late last summer, and a contracting dispute meant that a new firm did not begin its work until late January. By then, the coronavirus crisis was already underway."

Continue Reading
 

Breaking Banner

Pro-Trump reporter banned from White House briefing room for ignoring social distancing guidelines

Published

on

On Wednesday, the White House Correspondents Association announced that it would be banning One America News Network reporter Chanel Rion from the press briefing room, after she repeatedly refused to follow social distancing guidelines imposed as a safety precaution against coronavirus.

The WHCA taking action after OANN staffer Chanel Rion repeatedly broke the agreed-upon rules --> https://t.co/8uTRLaVSbd

— Geoff Bennett (@GeoffRBennett) April 1, 2020

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image